ApoptosisCell DeathAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCaspasesCaspase 3Antineoplastic AgentsProto-Oncogene Proteins c-bcl-2Apoptosis Regulatory ProteinsCause of DeathCell SurvivalCell Line, TumorDNA FragmentationCisplatinInhibitor of Apoptosis ProteinsDoxorubicinIn Situ Nick-End LabelingCombined Modality Therapybcl-2-Associated X ProteinSignal TransductionTreatment OutcomeMitochondriaCaspase InhibitorsCyclophosphamideEtoposideCells, CulturedTime FactorsCaspase 9NecrosisBreast NeoplasmsTumor Suppressor Protein p53Apoptosis Inducing FactorCaspase 8Tumor Cells, CulturedX-Linked Inhibitor of Apoptosis ProteinEnzyme ActivationFas Ligand ProteinDeathCytochromes cbcl-X ProteinDose-Response Relationship, DrugLung NeoplasmsNeoadjuvant TherapySurvival AnalysisReactive Oxygen SpeciesCell LineDrug Resistance, NeoplasmNeoplasmsCell ProliferationAmino Acid Chloromethyl KetonesPrognosisBlotting, WesternDisease-Free SurvivalCysteine Proteinase InhibitorsSurvival RatePoly(ADP-ribose) PolymerasesCASP8 and FADD-Like Apoptosis Regulating ProteinAntineoplastic Agents, PhytogenicNeoplasm StagingFlow CytometryProto-Oncogene ProteinsAnnexin A5PaclitaxelCell CycleAutophagyEnzyme InhibitorsDrug Administration ScheduleRNA, Small InterferingTransfectionMethotrexateMembrane Potential, MitochondrialCell DivisionImmunohistochemistryDNA DamageCarboplatinJurkat CellsVinblastineMice, Inbred C57BLTaxoidsDown-RegulationTNF-Related Apoptosis-Inducing LigandAntimetabolites, AntineoplasticGenes, bcl-2RNA, MessengerCaspase 7Gene Expression Regulation, NeoplasticTumor Necrosis Factor-alphaInduction Chemotherapybcl-2 Homologous Antagonist-Killer ProteinNeoplasm Recurrence, LocalDrug SynergismPhosphorylationAntibiotics, AntineoplasticFollow-Up StudiesReverse Transcriptase Polymerase Chain ReactionUp-RegulationMutationBH3 Interacting Domain Death Agonist ProteinAdenocarcinomaBleomycin